778
It is suggested that the patient had sulfasalazine-induced lupus, which manifested with serositis and pulmonary parenchymal involvement in the absence of joint symptoms.
 lupus, which manifested with serositis and pulmonary parenchymal involvement in the absence of joint symptoms: Effect; sulfasalazine: Treatment; sulfasalazine: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 lupus, which manifested with serositis and pulmonary parenchymal involvement in the absence of joint symptoms: Effect; sulfasalazine: Treatment; sulfasalazine: Treatment.Drug